Determinants of relapse periodicity in Plasmodium vivax malaria.

作者: Nicholas J White

DOI: 10.1186/1475-2875-10-297

关键词:

摘要: Plasmodium vivax is a major cause of febrile illness in endemic areas Asia, Central and South America, the horn Africa. infections are characterized by relapses malaria arising from persistent liver stages parasite (hypnozoites) which can be prevented only 8-aminoquinoline anti-malarials. Tropical P. at three week intervals if rapidly eliminated anti-malarials given for treatment, whereas temperate regions parts sub-tropics either long incubation or long-latency period between relapse - both cases approximating 8-10 months. The epidemiology different phenotypes has not been defined adequately despite obvious relevance to control elimination. number sporozoites inoculated anopheline mosquito an important determinant timing relapses. display remarkable periodicity explained. Evidence presented that proportion patients who have successive relatively constant factor activates hypnozoites leads regular interval systemic itself. It proposed large population harbours latent activated such as falciparum malaria. This explains high rates following malaria, heterologous genotypes relapses, higher people living compared with artificial infection studies, and, facilitating recombination genotypes, contributes genetic diversity particularly low transmission settings. Long-latency may more widespread prevalent than currently thought. These observations implications assessment radical treatment efficacy

参考文章(159)
M. Maryon, P. C. C. Garnham, P. G. Shute, The Madagascar strain of Plasmodium vivax. Archives de l'Institut Pasteur de Madagascar. ,vol. 47, pp. 173- 183 ,(1980)
W. A. Krotoski, R. Killick-Kendrick, L. C. Koontz, P. C. C. Garnham, R. S. Bray, R. W. Gwadz, R. Wolf, P. S. Stanfill, F. B. Cogswell, R. Sinden, W. E. Collins, Demonstration of Hypnozoites in Sporozoite-Transmitted Plasmodium vivax Infection* American Journal of Tropical Medicine and Hygiene. ,vol. 31, pp. 1291- 1293 ,(1982) , 10.4269/AJTMH.1982.31.1291
Hockwald Rs, Beutler E, Dern Rj, Clayman Cb, Alving As, Flanagan Cl, Arnold J, Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. Journal of Laboratory and Clinical Medicine. ,vol. 46, pp. 301- ,(1955)
A. S. Alving, Lillian Eichelberger, G. M. Jeffery, J. H. Edgcomb, E. H. Yount, D. Eyles, M. D. Young, J. Arnold, Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. Journal. National Malaria Society. ,vol. 9, pp. 285- ,(1950)
N. Singh, V. P. Sharma, A. K. Mishra, Radical treatment of vivax malaria in Madhya Pradesh, India. Indian journal of malariology. ,vol. 27, pp. 55- 56 ,(1990)
S. P. James, W. D. Nicol, P. G. Shute, Clinical and Parasitological Observations on Induced Malaria: (Section of Tropical Diseases and Parasitology). Journal of the Royal Society of Medicine. ,vol. 29, pp. 879- 894 ,(1936) , 10.1177/003591573602900802
G. ROBERT COATNEY, W. CLARK COOPER, DAVID S. RUHE, MARTIN D. YOUNG, ROBERT W. BURGESS, STUDIES IN HUMAN MALARIAXVIII. THE LIFE PATTERN OF SPOROZOITE-INDUCED ST. ELIZABETH STRAIN VIVAX MALARIA American Journal of Epidemiology. ,vol. 51, pp. 200- 215 ,(1950) , 10.1093/OXFORDJOURNALS.AJE.A119385
L. W. Hackett, Malaria in Europe. An Ecological Study. Malaria in Europe. An Ecological Study.. ,(1937)
S. P. James, P. G. Shute, Report on the first Results of Laboratory Work on Malaria in England. Publ. League' of Nations. ,vol. 3, ,(1926)
N. H. Fairley, Malaria.--I BMJ. ,vol. 2, pp. 825- 830 ,(1949) , 10.1136/BMJ.2.4632.825